Don’t miss your chance to secure a spot at BioVaria on 23./24. April 2018 to pitch your company to leading investors and biopharmaceutical decision makers, get invaluable guidance from industry experts in dedicated 1:1 meetings and network with fellow entrepreneurs, including startup keynote speaker Dr. Hella Kohlhof, CSO, Immunic…
The 3rd TechnologieAllianz Annual Conference will focus on science start-ups and their importance for the future of the German economy. Prominent speakers will explain how knowledge and technology transfer can help entrepreneurs, and introduce the available funding instruments. Further contributions will come from technology transfer experts,…
Eye-to-eye networking, acquiring deeper knowledge, sharing experiences, keeping informed about new developments – these are the aims of the TT workshop organized each year by Ascenion exclusively for its partner institutes. This year, 10 participants responsible for technology transfer at various research institutes und universities in Germany and…
Biotech NetWorkshop, organized by Ascenion and Max Planck Innovation, offers the opportunity for scientists interested in founding new start-ups to network with experienced founders of more mature life science companies from the Max Planck Society, the Helmholtz Association, the Leibniz Association and the Hanover Medical School.
We are looking…
Dear Partners and Clients,
We thank you for the enjoyable teamwork over the past year, and wish you and your families a merry Christmas and all the best for 2018.
Instead of sending Christmas cards this year, we have decided to make a donation to the charitable association "Eat to fight your disease e. V.". The project supports patients of the…
BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical industry. Top-tier academic institutions and universities from all over Europe will present over 60 attractive partnering and investment opportunities in the life-science field –…
Dr Ansgar Santel joined our Berlin office as Technology Development Manager in November 2017. He brings 15 years’ experience in the international biotech industry to the team, and in particular his expertise and enthusiasm for the translational development of innovative therapies. As Senior Scientist Translational & Clinical Research in a…
The art of a successful breast cancer operation lies in being able to remove as much cancerous tissue as possible and avoid the formation of metastases. Unfortunately, this is not achieved in approximately 40% of cases, increasing the risk of relapse for patients and possibly necessitating a second operation. In order to make primary operations…
Making cancer surgery more precise
23 October 2017, Munich – SurgVision BV, a spin-off from the Helmholtz Zentrum München, has been acquired by Milano-based Bracco Imaging S.p.A., a global leader in diagnostic imaging. The take-over enables the company to expand its diagnostic portfolio into the field of fluorescence image-guided surgery helping…
In this year's report we are pleased to present figures and highlights for 2016 together with selected project examples.
Based on research at our partner institutes, two products received market approval and three clinical trials started in 2016. In addition, Cardior Pharmaceuticals GmbH was founded and six portfolio companies received new or…
9 October 2017, Munich – Last week Ascenion GmbH and the Medical University of Innsbruck launched their cooperation with a joint kick-off event. The partners’ aim is to further strengthen the transfer of research results into application and enhance its efficiency.
‘The ideas and inventions developed here should also contribute commercially to…
OMEICOS Therapeutics, a spin-off from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), announced the second closing of its Series B financing round with US-based REMIGES Ventures. The financing enables OMEICOS to establish a US-based subsidiary in Cambridge Massachusetts and to expand its technology into the field…
TechnologieAllianz is the German association for knowledge and technology transfer (KTT) and brings together universities, national research institutions and transfer service providers in a nationwide network. TechnologieAllianz is promoting the development and recognition of the KTT profession in Germany and is also striving towards sharing best…
As a supporter of BioFIT Ascenion cordially invites all its partners to join this partnering event for open innovation, technology transfer and collaborative research in the life sciences, to take place on 28-29 November 2017 in Strasbourg, France.
BioFit brings together over 1,200 international leading stakeholders in the sector offering and…
Three further research institutes have decided to enter into partnership with Ascenion in recent months. This brings the number of long-term partner institutes and associated organisations supported by Ascenion to a total of 30, including institutes of the Helmholtz and Leibniz Associations, universities and university clinics, as well as various…
Around thirty startup founders and aspiring entrepreneurs met in Munich during this year’s Biotech NetWorkshop to learn from drug development experts and discuss strategies for bringing innovative therapies to the market. This year Ascenion and Max Planck Innovation welcomed attendees and speakers from over seven European countries and ten leading…
A career in academia? Or maybe rather in industry? This is a question that preoccupies nearly every scientist at some point. But you can have the best of both worlds: people who work in technology transfer move in science and business circles. Dr Dior Baumjohann, Technology Manager at Ascenion, introduces the varied areas of activity of a…
In the IBM DACH blog „Think“, Ascenion reports on the new possibilities and challenges in the area of digital health presented in the keynote talks at BioVaria. These include innovative ways to better diagnose and treat diseases, unique opportunities for interdisciplinary collaborations and the rapidly evolving dynamics of these markets.
Learn…
BioVaria Spin-off Awards go to Captain T Cell and Provirex
24 May 2017, Munich, Germany – On 22–23 May 2017, over 180 innovative minds gathered in Munich for the 10th BioVaria. Leading life scientists and their technology transfer partners presented the top projects originating from publicly funded research in Europe. Industry representatives and…
